Neurogenic Inflammation

SAN DIEGO — A novel, oral therapeutic for treatment of migraine was safe and well-tolerated in single ascending doses in a cohort of healthy adults, according to a speaker at the American Headache Society Annual Scientific Meeting.

ADE-G3-based cream was efficacious and well tolerated in adults with sensitive facial skin, according to a study.